These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 29528141)
1. Multi-omics analysis identifies pathways and genes involved in diffuse-type gastric carcinogenesis induced by E-cadherin, p53, and Smad4 loss in mice. Park JW; Kim MS; Voon DC; Kim SJ; Bae J; Mun DG; Ko SI; Kim HK; Lee SW; Kim DY Mol Carcinog; 2018 Jul; 57(7):947-954. PubMed ID: 29528141 [TBL] [Abstract][Full Text] [Related]
2. Cooperativity of E-cadherin and Smad4 loss to promote diffuse-type gastric adenocarcinoma and metastasis. Park JW; Jang SH; Park DM; Lim NJ; Deng C; Kim DY; Green JE; Kim HK Mol Cancer Res; 2014 Aug; 12(8):1088-99. PubMed ID: 24784840 [TBL] [Abstract][Full Text] [Related]
3. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer. Shimada S; Mimata A; Sekine M; Mogushi K; Akiyama Y; Fukamachi H; Jonkers J; Tanaka H; Eishi Y; Yuasa Y Gut; 2012 Mar; 61(3):344-53. PubMed ID: 21865403 [TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of metastatic gastric cancer cell lines from murine gastric adenocarcinoma lacking Smad4, p53, and E-cadherin. Park JW; Park DM; Choi BK; Kwon BS; Seong JK; Green JE; Kim DY; Kim HK Mol Carcinog; 2015 Nov; 54(11):1521-7. PubMed ID: 25307412 [TBL] [Abstract][Full Text] [Related]
5. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1. Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430 [TBL] [Abstract][Full Text] [Related]
6. In vivo CRISPR-Cas9 knockout screening using quantitative PCR identifies thymosin beta-4 X-linked that promotes diffuse-type gastric cancer metastasis. An HW; Kim SY; Kwon JW; Seok SH; Woo SH; Kim DY; Park JW Mol Carcinog; 2021 Sep; 60(9):597-606. PubMed ID: 34081824 [TBL] [Abstract][Full Text] [Related]
7. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389 [TBL] [Abstract][Full Text] [Related]
8. Smad4 and p53 synergize in suppressing autochthonous intestinal cancer. Park JW; Seo MJ; Cho KS; Kook MC; Jeong JM; Roh SG; Cho SY; Cheon JH; Kim HK Cancer Med; 2022 May; 11(9):1925-1936. PubMed ID: 35274815 [TBL] [Abstract][Full Text] [Related]
9. Stem Cells Antigen-1 Enriches for a Cancer Stem Cell-Like Subpopulation in Mouse Gastric Cancer. Park JW; Park JM; Park DM; Kim DY; Kim HK Stem Cells; 2016 May; 34(5):1177-87. PubMed ID: 26869189 [TBL] [Abstract][Full Text] [Related]
10. Mouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway Alterations. Seidlitz T; Chen YT; Uhlemann H; Schölch S; Kochall S; Merker SR; Klimova A; Hennig A; Schweitzer C; Pape K; Baretton GB; Welsch T; Aust DE; Weitz J; Koo BK; Stange DE Gastroenterology; 2019 Dec; 157(6):1599-1614.e2. PubMed ID: 31585123 [TBL] [Abstract][Full Text] [Related]
11. Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers. Cho SY; Park JW; Liu Y; Park YS; Kim JH; Yang H; Um H; Ko WR; Lee BI; Kwon SY; Ryu SW; Kwon CH; Park DY; Lee JH; Lee SI; Song KS; Hur H; Han SU; Chang H; Kim SJ; Kim BS; Yook JH; Yoo MW; Kim BS; Lee IS; Kook MC; Thiessen N; He A; Stewart C; Dunford A; Kim J; Shih J; Saksena G; Cherniack AD; Schumacher S; Weiner AT; Rosenberg M; Getz G; Yang EG; Ryu MH; Bass AJ; Kim HK Gastroenterology; 2017 Aug; 153(2):536-549.e26. PubMed ID: 28522256 [TBL] [Abstract][Full Text] [Related]
12. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer. Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735 [TBL] [Abstract][Full Text] [Related]
13. The keratin 17/YAP/IL6 axis contributes to E-cadherin loss and aggressiveness of diffuse gastric cancer. Li M; Rao X; Cui Y; Zhang L; Li X; Wang B; Zheng Y; Teng L; Zhou T; Zhuo W Oncogene; 2022 Feb; 41(6):770-781. PubMed ID: 34845376 [TBL] [Abstract][Full Text] [Related]
14. miR-324-3p promotes gastric cancer development by activating Smad4-mediated Wnt/beta-catenin signaling pathway. Sun GL; Li Z; Wang WZ; Chen Z; Zhang L; Li Q; Wei S; Li BW; Xu JH; Chen L; He ZY; Ying K; Zhang X; Xu H; Zhang DC; Xu ZK J Gastroenterol; 2018 Jun; 53(6):725-739. PubMed ID: 29103082 [TBL] [Abstract][Full Text] [Related]
15. Regulation of glycogen synthase kinase-3 by thymosin beta-4 is associated with gastric cancer cell migration. Ryu YK; Lee YS; Lee GH; Song KS; Kim YS; Moon EY Int J Cancer; 2012 Nov; 131(9):2067-77. PubMed ID: 22328534 [TBL] [Abstract][Full Text] [Related]
16. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells. Ma X; Wang B; Wang X; Luo Y; Fan W PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047 [TBL] [Abstract][Full Text] [Related]